Cyberonics: FDA Approves AspireSR Generator For VNS Therapy - Quick Facts

(RTTNews) - Cyberonics Inc. (CYBX) announced FDA approval of the AspireSR generator for the VNS Therapy System, the only VNS Therapy System that provides responsive stimulation to heart-rate increases that are often associated with seizures in people with epilepsy. The AspireSR generator uses a patent protected, customizable cardiac-based algorithm to detect relative heart-rate increases and deliver automatic stimulation.

The VNS Therapy System is an FDA-approved medical device specifically developed for the adjunctive treatment of drug-resistant epilepsy.

The company said it will provide more information on U.S. commercialization plans during the previously scheduled earnings call on June 4, 2015.